aldesleukin · Proleukin

Other

Approvedregulatory verdict

Evidence outlook

Approved: Renal Cell Carcinoma, Melanoma

Regulatory approval supersedes design-level evidence grading; the trials behind approval are preserved below as the drug's evidence history.

Latest reported trial: GOIRC (NCT00502034) · Phase 3 · missed primary endpoint · grade pending

Also approved (2)
CA
  • Adults with metastatic renal cell carcinoma and metastatic malignant melanoma (Proleukin product monograph, date of initial authorization)
Product first approved 1994pdf.hres.ca
EU
  • Proleukin 18 x 10^6 IU powder for solution for injection or infusion, authorised nationally (AT, DE, ES, FR, IT, NL and others)
EMA

How the evidence outlook works ↗

All registered studies

Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase. Studies where this drug served as another program's comparator, or is merely referenced, are listed separately below.

Phase 3 (35)
Melanoma
NCT00477906 · AVAX Technologies
2016-07 – 2021-01 · Melanoma
What this study did
NCT03233828 · Carman Giacomantonio
2019-10-30 – 2019-11-27 · Melanoma (Skin), Melanoma in Situ
What this study did
NCT00039234 · Maxim Pharmaceuticals
started 2002-09 · Melanoma (Skin), Metastatic Cancer
What this study did
NCT00006237 · SWOG Cancer Research Network
2000-08 – 2012-07 · Melanoma (Skin)
What this study did
NCT00019682 · National Cancer Institute (NCI)
1999-12 – 2011-05 · Recurrent Melanoma, Stage IIIA Skin Melanoma, Stage IIIB Skin Melanoma, Stage IIIC Skin Melanoma, Stage IV Skin Melanoma
What this study did
NCT00003027 · Eastern Cooperative Oncology Group
1997-11-13 – 2007-07 · Melanoma (Skin)
What this study did
NCT00002882 · M.D. Anderson Cancer Center
1995-11 – 2006-04 · Melanoma, Skin Cancer
What this study did
NCT00039000 · Agenus Inc.
2002-03 – 2005-12 · Malignant Melanoma
What this study did
Renal Cell Carcinoma
NCT00291369 · Centre Leon Berard
1999-12 – 2005-02 · Metastatic Renal Cell Carcinoma
What this study did
Other / comorbidity
NCT01704716 · St. Anna Kinderkrebsforschung
2002-02-01 – 2025-01-30 · Neuroblastoma
What this study did
NCT04724629 · University of Sao Paulo
2021-01-05 – 2021-07-30 · Covid19
What this study did
NCT01041638 · National Cancer Institute (NCI)
2009-12-21 – 2021-06-30 · High Risk Neuroblastoma
What this study did
NCT00006154 · National Institute of Allergy and Infectious Diseases (NIAID)
— · HIV Infections
What this study did
NCT00002702 · European Institute of Oncology
started 1992-09 · Head and Neck Cancer
What this study did
NCT00149162 · Assistance Publique - Hôpitaux de Paris
2005-03 – 2012-03 · Leukemia
What this study did
NCT00003991 · Maxim Pharmaceuticals
1998-07 – 2011-08 · Leukemia
What this study did
NCT00002945 · Roswell Park Cancer Institute
1996-12 – 2011-08 · Leukemia
What this study did
NCT00004978 · National Institute of Allergy and Infectious Diseases (NIAID)
2000-03 – 2008-11 · HIV Infections
What this study did
NCT00008203 · Herbert Irving Comprehensive Cancer Center
1996-05 – 2008-05 · Breast Cancer
What this study did
NCT00004128 · European Organisation for Research and Treatment of Cancer - EORTC
1999-09 – 2008-01 · Leukemia
What this study did
NCT00451984 · Aalborg University Hospital
started 2007-03 · HIV Infections, Hepatitis A, Hepatitis B
What this study did
NCT00013611 · University of Minnesota
2001-03 – 2007-01 · HIV Infection
What this study did
NCT00053820 · Medical Research Council
2002-07 – 2006-12 · Kidney Cancer
What this study did
NCT00002649 · National Cancer Institute (NCI)
1995-05 – 2006-11 · Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma
What this study did
NCT00002798 · National Cancer Institute (NCI)
1996-08 – 2006-09 · Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloblastic Leukemia With Maturation (M2), Childhood Acute Myeloblastic Leukemia Without Maturation (M1), Childhood Acute Myelomonocytic Leukemia (M4), Childhood Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Refractory Anemia, Refractory Anemia With Excess Blasts, Refractory Anemia With Excess Blasts in Transformation, Refractory Anemia With Ringed Sideroblasts, Secondary Myelodysplastic Syndromes, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
What this study did
NCT00416871 · Centre Leon Berard
est. completion 2006-02 · Kidney Cancer
What this study did
NCT00006363 · National Cancer Institute (NCI)
2000-11 – 2005-06 · Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Erythroid Leukemia (M6), Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monoblastic Leukemia and Acute Monocytic Leukemia (M5), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Childhood Acute Basophilic Leukemia, Childhood Acute Eosinophilic Leukemia, Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Minimally Differentiated Myeloid Leukemia (M0), Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monoblastic Leukemia and Acute Monocytic Leukemia (M5), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloblastic Leukemia With Maturation (M2), Childhood Acute Myeloblastic Leukemia Without Maturation (M1), Childhood Acute Myelomonocytic Leukemia (M4), Childhood Myelodysplastic Syndromes, de Novo Myelodysplastic Syndromes, Untreated Adult Acute Myeloid Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
What this study did
NCT00416429 · Centre Leon Berard
est. completion 2005-02 · Kidney Cancer
What this study did
NCT00003414 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
1997-10 – 2004-05 · Graft Versus Host Disease, Lymphoma
What this study did
NCT00053807 · European Organisation for Research and Treatment of Cancer - EORTC
1998-02 – 2004-01 · Kidney Cancer
What this study did
NCT00003126 · Loyola University
1997-06 – 2002-08 · Kidney Cancer
What this study did
NCT00001812 · National Cancer Institute (NCI)
1999-04 – 2000-08 · Candidiasis, Oral, Gastrointestinal Diseases, Stomatitis
What this study did
NCT00000949 · National Institute of Allergy and Infectious Diseases (NIAID)
est. completion 2000-07 · HIV Infections
What this study did
Phase 2/3 (2)
Melanoma
NCT03928275 · Carman Giacomantonio
2021-12-01 – 2022-09-01 · Cutaneous Metastatic Melanoma
What this study did
Other / comorbidity
Phase 2 (169)
Melanoma
NCT04562129 · H. Lee Moffitt Cancer Center and Research Institute
2020-09-24 – 2029-11 · Melanoma Stage III, Melanoma Stage IV, Inoperable Disease
What this study did
NCT01416831 · Providence Health & Services
2011-07-01 – 2026-12 · Metastatic Melanoma
What this study did
NCT00553618 · University of Louisville
2007-08 – 2026-08 · Metastatic Melanoma
What this study did
NCT06151847 · University of Kansas Medical Center
2023-12-21 – 2025-07-10 · Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Unresectable Melanoma
What this study did
NCT02748564 · Rutgers, The State University of New Jersey
2017-03-21 – 2023-06-05 · Metastatic Melanoma, Stage III Mucosal Melanoma of the Head and Neck, Stage IIIA Skin Melanoma, Stage IIIB Skin Melanoma, Stage IIIC Skin Melanoma, Stage IV Skin Melanoma, Stage IVA Mucosal Melanoma of the Head and Neck, Stage IVB Mucosal Melanoma of the Head and Neck, Stage IVC Mucosal Melanoma of the Head and Neck
What this study did
NCT03850691 · Masonic Cancer Center, University of Minnesota
2019-05-28 – 2022-12-12 · Metastatic Melanoma
What this study did
NCT00604136 · Hadassah Medical Organization
2008-07 – 2020-07 · Metastatic Melanoma
What this study did
NCT02203604 · CINJRegulatory
2014-11-26 – 2020-01-27 · Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
What this study did
NCT03476174 · Ralph Hauke
2018-05-07 – 2019-10-16 · Melanoma
What this study did
NCT01266603 · M.D. Anderson Cancer Center
2011-02-22 – 2018-11-01 · Melanoma
What this study did
NCT01124734 · Milton S. Hershey Medical Center
2010-05 – 2018-07-01 · Malignant Melanoma
What this study did
NCT01258855 · National Cancer Institute (NCI)
2011-01-18 – 2018-03-29 · Metastatic Melanoma, Recurrent Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7
What this study did
NCT01754376 · Massachusetts General Hospital
2013-01 – 2016-03 · Melanoma
What this study did
NCT01833767 · Western Regional Medical Center
2012-10 – 2015-12 · Metastatic Melanoma
What this study did
NCT01480323 · University Hospital Tuebingen
2012-02 – 2015-06 · Malignant Melanoma
What this study did
NCT01702896 · Western Regional Medical Center
2012-09 – 2014-12 · Melanoma Metastatic
What this study did
NCT01495572 · National Cancer Institute (NCI)
2011-12 – 2014-02 · Metastatic Melanoma, Skin Cancer
What this study did
NCT00002845 · Blumenthal Cancer Center at Carolinas Medical Center
started 1995-09 · Melanoma (Skin)
What this study did
NCT00513604 · National Cancer Institute (NCI)
2007-06 – 2012-11 · Melanoma, Malignant Melanoma, Melanoma, Experimental, Experimental Melanomas
What this study did
NCT00863330 · Wake Forest University Health Sciences
2009-02 – 2012-07 · Melanoma (Skin)
What this study did
NCT00665470 · National Cancer Institute (NCI)
2008-04 – 2012-04 · Skin Cancer, Metastatic Melanoma
What this study did
NCT01355562 · Loma Linda University
2011-03 – 2012-02 · Melanoma, Metastatic Kidney Cancer
What this study did
NCT01160445 · National Cancer Institute (NCI)
2010-06 – 2012-01 · Metastatic Melanoma, Metastatic Renal Cancer
What this study did
NCT01271907 · National Cancer Institute (NCI)
2011-04-15 – 2011-12-08 · Metastatic Cutaneous Melanoma
What this study did
NCT00726739 · Masonic Cancer Center, University of Minnesota
2008-06 – 2011-06 · Stage IV Melanoma
What this study did
NCT00001832 · National Cancer Institute (NCI)
1999-08 – 2010-05 · Melanoma, Neoplasm Metastasis
What this study did
NCT00505635 · M.D. Anderson Cancer Center
2007-03 – 2010-04 · Melanoma
What this study did
NCT00204581 · University Hospital Tuebingen
2003-08 – 2009-12 · Melanoma
What this study did
NCT00080353 · National Cancer Institute (NCI)
2004-03 – 2008-12 · Melanoma
What this study did
NCT00019669 · National Cancer Institute (NCI)
1999-10 – 2007-10 · Melanoma (Skin)
What this study did
NCT00019994 · National Cancer Institute (NCI)
1999-10 – 2007-10 · Melanoma (Skin)
What this study did
NCT00020358 · National Cancer Institute (NCI)
2000-09 – 2007-10 · Melanoma (Skin)
What this study did
NCT00019331 · National Cancer Institute (NCI)
1997-10 – 2007-05 · Colorectal Cancer, Endometrial Cancer, Head and Neck Cancer, Liver Cancer, Lung Cancer, Melanoma (Skin), Pancreatic Cancer, Testicular Germ Cell Tumor, Unspecified Adult Solid Tumor, Protocol Specific
What this study did
NCT00203879 · University of Chicago
2002-02 – 2007-05 · Metastatic Melanoma
What this study did
NCT00138229 · National Institutes of Health Clinical Center (CC)
2005-07 – 2007-04 · Melanoma (Skin)
What this study did
NCT00019448 · National Cancer Institute (NCI)
1998-09 – 2007-03 · Stage IV Melanoma, Recurrent Melanoma
What this study did
NCT00020475 · National Cancer Institute (NCI)
2001-02 – 2007-03 · Extraocular Extension Melanoma, Recurrent Intraocular Melanoma
What this study did
NCT00303836 · National Cancer Institute (NCI)
2005-11 – 2007-01 · Recurrent Melanoma, Stage IV Melanoma
What this study did
NCT00072085 · National Cancer Institute (NCI)
2003-09 – 2006-07 · Melanoma (Skin)
What this study did
NCT00006113 · University of Southern California
1999-06 – 2006-04 · Melanoma (Skin)
What this study did
NCT00005949 · National Cancer Institute (NCI)
2001-03 – 2006-03 · Recurrent Melanoma, Stage IV Melanoma
What this study did
NCT00003568 · University of Illinois at Chicago
1998-11 – 2005-12 · Melanoma (Skin)
What this study did
NCT00020397 · National Cancer Institute (NCI)
2000-11 – 2005-07 · Melanoma (Skin)
What this study did
NCT00085579 · Memorial Sloan Kettering Cancer Center
2004-03 – 2005-03 · Melanoma (Skin)
What this study did
NCT00054535 · National Cancer Institute (NCI)
2003-01 – 2004-09 · Melanoma (Skin)
What this study did
NCT00022438 · National Cancer Institute (NCI)
2001-06 – 2004-08 · Melanoma (Skin)
What this study did
NCT00002535 · St. Luke's Medical Center
1993-07 – 2004-07 · Melanoma (Skin)
What this study did
Phase 1/2 (74)
Melanoma
NCT01590069 · M.D. Anderson Cancer Center
2012-06-28 – 2029-04-30 · Metastatic Malignant Neoplasm in the Lung, Metastatic Melanoma, Metastatic Osteosarcoma, Metastatic Renal Cell Cancer, Sarcoma, Stage IV Cutaneous Melanoma AJCC v6 and v7, Stage IV Osteosarcoma AJCC v7, Stage IV Renal Cell Cancer AJCC v7
What this study did
NCT06237881 · M.D. Anderson Cancer Center
2024-01-31 – 2029-01-01 · Advanced Solid Tumor, Melanoma, Lung Neoplasms, Head and Neck Neoplasms
What this study did
NCT07063875 · St Vincent's Hospital, Sydney
2025-06-01 – 2028-09-01 · Uveal Melanoma, Metastatic Uveal Melanoma, Metastatic Uveal Melanoma in the Liver
What this study did
NCT05267626 · Aulos Bioscience, Inc.
2022-04-04 – 2027-02-28 · Advanced Solid Tumor, Metastatic Cancer, Cutaneous Melanoma, Non-Small Cell Lung Cancer
What this study did
NCT03111901 · William Grosh, MD
2018-10-29 – 2023-10 · Carcinoma, Renal Cell, Melanoma
What this study did
NCT01409187 · M.D. Anderson Cancer Center
2011-10 – 2016-10 · Melanoma
What this study did
NCT01278940 · Oslo University Hospital
2002-03 – 2015-12 · Malignant Melanoma
What this study did
NCT00937625 · Inge Marie Svane
2009-06 – 2015-01 · Melanoma
What this study did
NCT00004025 · Genzyme, a Sanofi Company
started 1999-03 · Melanoma (Skin)
What this study did
NCT01273181 · National Cancer Institute (NCI)
2010-12 – 2012-12 · Metastatic Cancer, Metastatic Renal Cancer, Metastatic Melanoma
What this study did
NCT01191034 · Cliniques universitaires Saint-Luc- Université Catholique de Louvain
2010-08 – 2012-08-01 · Metastatic Melanoma
What this study did
NCT00553306 · Fred Hutchinson Cancer Center
2007-09 – 2012-03 · Recurrent Melanoma, Stage IV Melanoma
What this study did
NCT00945269 · Fred Hutchinson Cancer Center
2009-07 – 2011-01 · Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma
What this study did
NCT00279058 · Hadassah Medical Organization
2005-12 – 2008-12 · Metastatic Melanoma
What this study did
NCT00062036 · National Institutes of Health Clinical Center (CC)
2003-06 – 2008-09 · Melanoma (Skin)
What this study did
NCT00058279 · National Cancer Institute (NCI)
2003-02 – 2006-08 · Intraocular Melanoma, Melanoma (Skin)
What this study did
NCT00019214 · National Cancer Institute (NCI)
1997-04 – 2006-07 · Melanoma (Skin)
What this study did
NCT00002786 · Fred Hutchinson Cancer Center
1995-10 – 2006-03 · Melanoma (Skin)
What this study did
NCT00003229 · Duke University
1997-07 – 2005-02 · Melanoma (Skin)
What this study did
Renal Cell Carcinoma
NCT01038778 · National Cancer Institute (NCI)
2009-10-29 – 2027-02-12 · Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7, Stage IV Renal Cell Cancer AJCC v7
What this study did
NCT03474497 · Megan Daly, MD
2019-05-20 – 2026-02 · Non Small Cell Lung Cancer, Metastatic Melanoma, Metastatic Renal Cell Carcinoma, Head and Neck Squamous Cell Carcinoma
What this study did
NCT02989714 · University of Michigan Rogel Cancer Center
2017-03-16 – 2020-06-23 · Renal Cell Carcinoma
What this study did
NCT01550367 · Leonard Appleman
2012-03 – 2019-02 · Metastatic Renal Cell Carcinoma
What this study did
NCT00277017 · New Mexico Cancer Research Alliance
2000-09 – 2005-08 · Kidney, Cancer
What this study did
Other / comorbidity
NCT06598371 · M.D. Anderson Cancer Center
2024-11-21 – 2041-08-01 · Select Advanced Solid Tumors
What this study did
NCT07591649 · Masonic Cancer Center, University of Minnesota
2026-05-08 – 2035-03-01 · Relapsed Adult AML, Refractory AML, Acute Myelogenous Leukemia
What this study did
NCT07389239 · University of Chicago
2026-09-09 – 2031-12-10 · Ovarian Cancer, Advanced Malignant Solid Tumor
What this study did
NCT07681596 · AstraZeneca
2026-07-27 – 2031-03-06 · Relapsed or Refractory Multiple Myeloma
What this study did
NCT06158828 · Washington University School of Medicine
2024-11-15 – 2030-05-31 · AML, Childhood, Aml, Acute Myeloid Leukemia, Pediatric, Acute Myeloid Leukemia
What this study did
NCT06119685 · Indapta Therapeutics, INC.
2023-10-25 – 2029-12-31 · NHL, Multiple Myeloma, Blood Cancer, Refractory Non-Hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma, Refractory Multiple Myeloma, Relapsed Multiple Myeloma
What this study did
NCT07651319 · The Methodist Hospital Research Institute
2026-09-01 – 2029-12 · Alzheimer Dementia (AD)
What this study did
NCT07255664 · CuraCell TX AB
2025-11-13 – 2029-04 · Metastatic Colorectal Cancer, Prostate Cancer Metastatic, Prostate Cancer Locally Advanced
What this study did
NCT03243058 · Jay S. Skyler
2023-06 – 2028-12 · Diabetes Mellitus, Type 1, Diabetes, Diabetes, Autoimmune
What this study did
NCT05821686 · Nova Scotia Health Authority
2026-01-02 – 2028-04 · Triple Negative Breast Cancer
What this study did
NCT04263831 · Boston Children's Hospital
2021-03-11 – 2027-12-30 · Crohn Disease
What this study did
NCT05307874 · ImCheck Therapeutics, an Ipsen company
2022-05-04 – 2025-10-09 · Solid Tumor, Adult
What this study did
NCT04673617 · Artiva Biotherapeutics, Inc.
2021-03-29 – 2025-10-06 · Non Hodgkin Lymphoma
What this study did
NCT02858310 · National Cancer Institute (NCI)
2017-01-27 – 2025-07-02 · Papillomavirus Infections, Cervical Intraepithelial Neoplasia, Carcinoma In Situ, Vulvar Neoplasms, Vulvar Diseases
What this study did
NCT02586831 · Camillo Ricordi and Jay Skyler
2024-06-01 – 2024-06-01 · Diabetes Mellitus, Type 1, Hypoglycemia, Autoimmune Diseases, Diabetes Mellitus
What this study did
NCT03970954 · Assistance Publique - Hôpitaux de Paris
2021-01-05 – 2024-03-20 · Recurrent Miscarriage
What this study did
NCT05207722 · Celularity Incorporated
2022-04-14 – 2024-02-15 · Metastatic HER2 Positive Gastroesophageal Junction Cancer
What this study did
NCT01701479 · St. Anna Kinderkrebsforschung
2012-01 – 2020-12 · Neuroblastoma
What this study did
NCT02408016 · Fred Hutchinson Cancer Center
2015-05-22 – 2020-06-30 · Advanced Pleural Malignant Mesothelioma, HLA-A*0201 Positive Cells Present, Recurrent Non-Small Cell Lung Carcinoma, Recurrent Pleural Malignant Mesothelioma, Stage III Non-Small Cell Lung Cancer AJCC v7, Stage III Pleural Malignant Mesothelioma AJCC v7, Stage IIIA Non-Small Cell Lung Cancer AJCC v7, Stage IIIB Non-Small Cell Lung Cancer AJCC v7, Stage IV Non-Small Cell Lung Cancer AJCC v7, Stage IV Pleural Malignant Mesothelioma AJCC v7, WT1 Positive
What this study did
NCT01640301 · Fred Hutchinson Cancer Center
2012-12-06 – 2020-03-20 · Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Therapy-Related Acute Myeloid Leukemia, Donor, Hematopoietic Cell Transplant Recipient, HLA-A*0201 Positive Cells Present, Recurrent Acute Myeloid Leukemia
What this study did
NCT03040401 · Vastra Gotaland Region
2017-02-15 – 2019-12-15 · Leukemia, Myelomonocytic, Chronic
What this study did
NCT02173093 · University of Virginia
2014-11 – 2019-12 · Disseminated Neuroblastoma, Recurrent Neuroblastoma
What this study did
NCT02714959 · Seoul National University Hospital
2016-03 – 2019-06-12 · Encephalitis
What this study did
NCT03113773 · Cambridge University Hospitals NHS Foundation Trust
2017-05-11 – 2019-02-21 · Ischemic Heart Disease
What this study did
NCT02417870 · Anil K. Chandraker, MD
2015-09 – 2018-04 · Kidney Transplantation
What this study did
NCT02265809 · Cambridge University Hospitals NHS Foundation Trust
2014-10-03 – 2016-05-26 · Type 1 Diabetes
What this study did
Phase 1 (124)
Melanoma
NCT07700121 · Abramson Cancer Center at Penn Medicine
2026-10-01 – 2029-10-01 · Unresectable or Metastatic Melanoma
What this study did
NCT04625205 · BioNTech US Inc.
2020-12-01 – 2025-03-26 · Unresectable Melanoma, Metastatic Melanoma
What this study did
NCT00020267 · National Cancer Institute (NCI)
started 2000-07 · Lung Cancer, Adult Soft Tissue Sarcoma, Colorectal Cancer, Bone Cancer, Ovarian Sarcoma, Melanoma, Colon Cancer, Rectal Cancer, Breast Cancer, Eye Cancer, Uterine Sarcoma
What this study did
NCT01789827 · Mayo Clinic
2014-03 – 2018-06-27 · Stage IV Skin Melanoma
What this study did
NCT01603212 · M.D. Anderson Cancer Center
2013-07-18 – 2017-07-05 · Melanoma
What this study did
NCT01409174 · M.D. Anderson Cancer Center
2013-02 – 2016-05 · Melanoma
What this study did
NCT00019175 · National Cancer Institute (NCI)
started 1996-08 · Melanoma (Skin)
What this study did
NCT00304460 · National Cancer Institute (NCI)
2006-03-13 – 2014-02-27 · Metastatic Melanoma, Renal Cell Cancer
What this study did
NCT00276835 · Northwestern University
2005-11 – 2014-01 · Kidney Cancer, Melanoma (Skin)
What this study did
NCT00418496 · Ohio State University Comprehensive Cancer Center
2006-11-08 – 2013-10 · Renal Cancer, Melanoma
What this study did
NCT00112242 · Centre Hospitalier Universitaire Vaudois
2004-02 – 2013-03 · Melanoma
What this study did
NCT00470015 · Mayo Clinic
2007-03 – 2013-01-02 · Melanoma (Skin)
What this study did
NCT00970996 · M.D. Anderson Cancer Center
2009-09 – 2012-12 · Melanoma
What this study did
NCT01339663 · Fred Hutchinson Cancer Center
2012-03 – 2012-12 · Recurrent Melanoma, Stage IV Melanoma
What this study did
NCT00438984 · Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
2006-12 – 2012-02 · Recurrent Melanoma, Stage IV Melanoma
What this study did
NCT01106235 · Fred Hutchinson Cancer Center
2010-04 – 2011-11 · Stage IV Melanoma
What this study did
NCT00091104 · National Institutes of Health Clinical Center (CC)
2004-07 – 2010-10 · Melanoma (Skin)
What this study did
NCT00085462 · National Institutes of Health Clinical Center (CC)
2004-05 – 2008-09 · Melanoma (Skin)
What this study did
NCT00045149 · Fred Hutchinson Cancer Center
2002-10 – 2005-06 · Melanoma (Skin)
What this study did
NCT00006022 · Virginia Commonwealth University
2000-09 – 2004-01 · Kidney Cancer, Melanoma (Skin)
What this study did
NCT00005943 · University of Colorado, Denver
2000-02 – 2001-09 · Melanoma (Skin)
What this study did
Renal Cell Carcinoma
NCT03841110 · Fate Therapeutics
2019-02-15 – 2022-11-15 · Advanced Solid Tumors, Lymphoma, Gastric Cancer, Colorectal Cancer, Head and Neck Cancer, Squamous Cell Carcinoma, EGFR Positive Solid Tumor, HER2-positive Breast Cancer, Hepatocellular Carcinoma, Small Cell Lung Cancer, Renal Cell Carcinoma, Pancreas Cancer, Melanoma, NSCLC, Urothelial Carcinoma, Cervical Cancer, Microsatellite Instability, Merkel Cell Carcinoma
What this study did
NCT03260504 · University of Washington
2018-08-28 – 2022-07-26 · Advanced Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer, Metastatic Clear Cell Renal Cell Carcinoma
What this study did
NCT04596033 · Genocea Biosciences, Inc.
2020-11-11 – 2022-06-27 · Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma of Head and Neck, Urothelial Carcinoma, Renal Cell Carcinoma, Small-cell Lung Cancer, Cutaneous Squamous Cell Carcinoma, Anal Squamous Cell Carcinoma, Merkel Cell Carcinoma
What this study did
Other / comorbidity
NCT04629729 · Fate Therapeutics
2021-07-12 – 2039-09-30 · Lymphoma, B-Cell, Chronic Lymphocytic Leukemia, Precursor B-Cell Acute Lymphoblastic Leukemia
What this study did
NeoTIL in Advanced Solid Tumorsactive not recruiting
NCT04643574 · Centre Hospitalier Universitaire Vaudois
2021-03-09 – 2029-12 · Solid Tumor, Adult
What this study did
NCT05802056 · Mayo Clinic
2023-11-29 – 2029-06-24 · Clinical Stage IV Gastric Cancer AJCC v8, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Metastatic Gastric Carcinoma, Metastatic Malignant Neoplasm in the Peritoneum
What this study did
NCT06904066 · National Cancer Institute (NCI)
2026-10-28 – 2029-04-30 · Malignancy, Hematologic, Neoplasms, Hematologic, Neoplasms, Hematopoietic, Blood Cancer, Hematological Neoplasms, Hematopoietic Malignancies, Dysmyelopoietic Syndromes, Hematopoetic Myelodysplasia, Myeloid Leukemia, Acute, Nonlymphoblastic Leukemia, Acute, Leukemia, Lymphocytic, Acute
What this study did
NCT06677710 · Indapta Therapeutics, INC.
2026-06-30 – 2028-12-31 · Multiple Sclerosis, Primary Progressive Multiple Sclerosis (PPMS), Secondary Progressive Multiple Sclerosis (SPMS), Non-Active Secondary Progressive Multiple Sclerosis, Non-Active SPMS, Autoimmune Diseases of the Nervous System, Nervous System Diseases, Autoimmune Diseases, Demyelinating Diseases, Immune System Diseases, Demyelinating Autoimmune Diseases, Central Nervous System (CNS)
What this study did
NCT03546426 · Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
2019-12-12 – 2028-09 · Mesothelioma, Malignant, PD-L1 Negative, Advanced Cancer, Progressive Disease
What this study did
NCT05493566 · Emory University
2022-11-01 – 2028-01-07 · Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8, Stage IVB Lung Cancer AJCC v8
What this study did
NCT01937468 · Dana-Farber Cancer Institute
2013-11 – 2027-12 · Chronic Graft Versus Host Disease, Chronic GVHD, Complications of Organ Transplant Stem Cells
What this study did
NCT06395038 · The Methodist Hospital Research Institute
2024-05-06 – 2026-04-30 · Frontotemporal Degeneration
What this study did
NCT06236425 · H. Lee Moffitt Cancer Center and Research Institute
2024-03-14 – 2025-04-09 · Squamous Cell Carcinoma of Head and Neck, Metastatic Squamous Cell Carcinoma
What this study did
NCT06307301 · The Methodist Hospital Research Institute
2021-10-28 – 2023-12-31 · Amyotrophic Lateral Sclerosis
What this study did
NCT04023071 · Fate Therapeutics
2019-10-04 – 2023-10-23 · Acute Myelogenous Leukemia, B-cell Lymphoma
What this study did
NCT04887259 · Lava Therapeutics
2021-07-12 – 2023-09-06 · Chronic Lymphocytic Leukemia, Multiple Myeloma, Acute Myeloid Leukemia
What this study did
NCT03862833 · Nantes University Hospital
2019-05-07 – 2023-08-29 · Hematopoietic Stem Cell Transplantation
What this study did
NCT04862767 · Autotelicbio
2021-03-09 – 2023-08-21 · Solid Tumor
What this study did
NCT05395052 · Fate Therapeutics
2022-05-31 – 2023-08-11 · Non Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Ovarian Cancer, Pancreatic Cancer, Head and Neck Cancer, GastroEsophageal Cancer
What this study did
NCT04551885 · Fate Therapeutics
2020-09-07 – 2023-08-11 · Solid Tumor, Adult
What this study did
NCT03019666 · Masonic Cancer Center, University of Minnesota
2017-10-18 – 2022-08-15 · Multiple Myeloma, Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Mantle-Cell Lymphoma, Follicular Lymphoma, Indolent B Cell Lymphoma, Primary Mediastinal Lymphoma, Lymphoplasmacytic Lymphoma
What this study did
NCT05821153 · The Methodist Hospital Research Institute
2019-06-19 – 2022-04-27 · Alzheimer Disease
What this study did
NCT03912831 · Gilead Sciences
2019-04-30 – 2022-02-18 · Human Papillomavirus (HPV) 16+ Relapsed/Refractory Cancer
What this study did
NCT04630769 · Masonic Cancer Center, University of Minnesota
2021-04-02 – 2022-01-01 · Ovarian Cancer, Fallopian Tube Adenocarcinoma, Primary Peritoneal Cavity Cancer
What this study did
NCT02876510 · Immatics US, Inc.
2017-06-30 – 2021-09-22 · Cancer, Solid Tumor
What this study did
NCT03241719 · Brigham and Women's Hospital
2017-10-17 – 2021-07-21 · Amputation, Traumatic, Amputation;Traumatic;Old, Face Injury, Face; Deformity, Abdominal Wall Defect
What this study did
NCT01662804 · Memorial Sloan Kettering Cancer Center
2012-08-06 – 2021-05-25 · Neuroblastoma
What this study did
NCT02200445 · Scott B. Snapper, MD PHD
2015-02 – 2021-03 · Ulcerative Colitis
What this study did
NCT03081780 · Masonic Cancer Center, University of Minnesota
2017-04-27 – 2020-12-01 · Refractory Acute Myelogenous Leukemia, Relapsed Acute Myelogenous Leukemia
What this study did
Phase 4 (8)
Melanoma
NCT01856023 · Clinigen, Inc.
2013-05 – 2015-07 · Metastatic Melanoma
What this study did
NCT01683188 · Clinigen, Inc.
2012-08 – 2014-11 · Metastatic Melanoma
What this study did
Renal Cell Carcinoma
NCT00414765 · Novartis Pharmaceuticals
2008-09-03 – 2010-03-28 · Metastatic Renal Cell Carcinoma, Metastatic Melanoma
What this study did
Other / comorbidity
NCT02949492 · King's College London
2017-12-12 – 2019-01-31 · Transplantation, Liver Diseases
What this study did
NCT01347996 · Cytovia, Inc.
2009-07 – 2014-06 · Acute Myeloid Leukemia
What this study did
NCT02300623 · Juan A. Arnaiz
2000-03 – 2013-04 · HIV
What this study did
NCT00352885 · Emory University
2006-10-06 – 2010-05-17 · Depression
What this study did
NCT00006864 · Case Comprehensive Cancer Center
2000-07 – 2007-07 · Kidney Cancer
What this study did
Early phase / not applicable (10)
Other / comorbidity
NCT07610538 · Cambridge University Hospitals NHS Foundation Trust
2026-03-31 – 2028-12-01 · Coronary Artery Disease, Myocardial Infarction (MI), CABG
What this study did
NCT00006441 · National Institute of Allergy and Infectious Diseases (NIAID)
2003-02 – 2008-10 · HIV Infections
What this study did
NCT00001131 · National Institute of Allergy and Infectious Diseases (NIAID)
2004-05 – 2007-06 · HIV Infections
What this study did
NCT00038259 · National Institute of Allergy and Infectious Diseases (NIAID)
est. completion 2006-05 · HIV Infections
What this study did
NCT00015652 · National Institute of Allergy and Infectious Diseases (NIAID)
est. completion 2005-03 · HIV Infections, Hepatitis C
What this study did
NCT00899821 · NYU Langone Health
2000-06 – 2004-12 · Head and Neck Cancer
What this study did
NCT00015704 · National Institute of Allergy and Infectious Diseases (NIAID)
est. completion 2004-11 · HIV Infections
What this study did
NCT00000923 · National Institute of Allergy and Infectious Diseases (NIAID)
est. completion 2004-08 · HIV Infections
What this study did
NCT00000875 · National Institute of Allergy and Infectious Diseases (NIAID)
est. completion 2003-04 · HIV Infections
What this study did
NCT00000804 · National Institute of Allergy and Infectious Diseases (NIAID)
est. completion 2002-08 · HIV Infections
What this study did
Used as active comparator (2)

Other programs' studies in which this drug was the registered active-comparator arm: a marker of standard-of-care status, not evidence of this drug's own progression.

Phase 2 (2)
Melanoma
Renal Cell Carcinoma
NCT01274273 · University of Aarhus
2009-10 – 2015-12 · Metastatic Renal Cell Carcinoma
What this study did
Studied as part of a combination product (183)

Studies of a fixed-dose combination that contains this drug. The combination is the product under test, so these are that product's evidence rather than this one's; the link is kept because the drug really was administered.

Phase 3 (2)
Melanoma
NCT02278887 · The Netherlands Cancer Institute
2014-09-23 – 2023-12-31 · Metastatic Melanoma
What this study did
Other / comorbidity
NCT00026312 · National Cancer Institute (NCI)
2001-10-26 – 2025-12-31 · Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Recurrent Neuroblastoma, Regional Neuroblastoma, Stage 4 Neuroblastoma, Stage 4S Neuroblastoma
What this study did
Phase 2 (74)
Melanoma
NCT07651618 · East Metropolitan Health Service, Australia
2026-07 – 2032-04 · Melanoma (Skin Cancer), Melanoma Metastatic
What this study did
NCT00338377 · M.D. Anderson Cancer Center
2006-02-01 – 2030-02-28 · Melanoma
What this study did
NCT06630611 · Vall d'Hebron Institute of Oncology
2025-01-15 – 2029-09 · Melanoma, Non Small Cell Lung Cancer, Cervical Cancer
What this study did
NCT03166397 · Sheba Medical Center
2017-06-05 – 2026-06-01 · Malignant Melanoma Stage IV
What this study did
NCT01659151 · H. Lee Moffitt Cancer Center and Research Institute
2012-08-03 – 2025-08-19 · Metastatic Melanoma
What this study did
NCT02027935 · M.D. Anderson Cancer Center
2015-01-22 – 2024-04-12 · Metastatic Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7
What this study did
NCT02500576 · M.D. Anderson Cancer Center
2015-08-07 – 2022-10-12 · Metastatic Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7
What this study did
NCT01993719 · National Cancer Institute (NCI)
2013-12-12 – 2022-07-06 · Metastatic Melanoma
What this study did
NCT01807182 · Fred Hutchinson Cancer Center
2013-08-20 – 2021-08-26 · Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Metastatic Melanoma
What this study did
NCT01967823 · National Cancer Institute (NCI)
2013-10-24 – 2020-04-06 · Melanoma, Meningioma, Breast Cancer, Non-Small Cell Lung Cancer, Hepatocellular Cancer
What this study did
NCT01883323 · University Health Network, Toronto
2013-06 – 2018-04 · Metastatic, Stage III or Stage IV, Melanoma
What this study did
NCT01814046 · National Cancer Institute (NCI)
2013-03-01 – 2017-05-31 · Metastatic Ocular Melanoma, Metastatic Uveal Melanoma
What this study did
NCT02111863 · National Cancer Institute (NCI)
2014-02-21 – 2016-07-21 · Melanoma, Skin Cancer
What this study did
NCT00670748 · National Cancer Institute (NCI)
2008-05-29 – 2016-06-29 · Metastatic Melanoma, Metastatic Renal Cell Cancer, Metastatic Cancer
What this study did
NCT02062359 · National Cancer Institute (NCI)
2014-02 – 2016-02 · Metastatic Cancer, Metastatic Melanoma
What this study did
NCT01995344 · The Christie NHS Foundation Trust
2014-03-01 – 2015-07-24 · Metastatic Melanoma
What this study did
NCT00706992 · National Cancer Institute (NCI)
2008-06 – 2012-11 · Melanoma
What this study did
NCT00509496 · National Cancer Institute (NCI)
2007-06 – 2012-07 · Skin Cancer, Melanoma
What this study did
NCT00509288 · National Cancer Institute (NCI)
2007-06 – 2012-07 · Melanoma, Skin Cancer
What this study did
NCT01369875 · National Cancer Institute (NCI)
2011-06-17 – 2012-02-14 · Metastatic Melanoma, Skin Cancer
What this study did
NCT00923195 · National Cancer Institute (NCI)
2008-12 – 2011-08 · Melanoma, Skin Cancer
What this study did
NCT00612222 · National Cancer Institute (NCI)
2008-01 – 2011-03 · Metastatic Melanoma, Skin Cancer
What this study did
NCT00610311 · National Cancer Institute (NCI)
2008-01 – 2011-02 · Metastatic Melanoma, Skin Cancer
What this study did
NCT00059475 · National Cancer Institute (NCI)
2003-04 – 2010-05 · Melanoma
What this study did
NCT00085423 · Dartmouth-Hitchcock Medical Center
2004-02 – 2010-02 · Melanoma (Skin)
What this study did
NCT00704938 · National Institutes of Health Clinical Center (CC)
2008-06 – 2009-08 · Kidney Cancer, Melanoma (Skin), Unspecified Adult Solid Tumor, Protocol Specific
What this study did
NCT00328861 · National Cancer Institute (NCI)
2006-05 – 2009-04 · Metastatic Melanoma, Metastatic Kidney Cancer
What this study did
NCT00314106 · National Cancer Institute (NCI)
2006-04 – 2009-03 · Metastatic Melanoma
What this study did
Renal Cell Carcinoma
NCT07925333 · Beth Israel Deaconess Medical Center
2027-04-26 – 2030-03-01 · Kidney Cancers, Renal Cell Carcinoma (Kidney Cancer)
What this study did
NCT02306954 · Providence Health & Services
2014-12 – 2026-12 · Renal Cell Carcinoma
What this study did
Other / comorbidity
NCT01174121 · National Cancer Institute (NCI)
2010-08-26 – 2029-12-27 · Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer, Metastatic Ovarian Cancer, Metastatic Breast Carcinoma, Metastatic Endocrine Tumors/ Neuroendocrine Tumors
What this study did
NCT07288073 · Karam Khaddour, MD, MS
2026-02-10 – 2029-06-29 · Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma, Metastatic Cutaneous Squamous Cell Carcinoma, Skin Cancer
What this study did
NCT03412877 · National Cancer Institute (NCI)
2018-09-06 – 2029-03-23 · Endocrine Tumors, Non-Small Cell Lung Cancer, Ovarian Cancer, Breast Cancer, Gastrointestinal/Genitourinary Cancers, Neuroendocrine Tumors, Multiple Myeloma
What this study did
NCT04354025 · Washington University School of Medicine
2023-06-30 – 2028-07-31 · Refractory Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia
What this study did
NCT07647068 · Joal Beane
2027-02-15 – 2027-12-31 · Locally Advanced Gastrointestinal Stromal Tumor, Metastatic Gastrointestinal Stromal Tumor, Recurrent Gastrointestinal Stromal Tumor, Refractory Malignant Gastrointestinal Stromal Tumor, Unresectable Malignant Gastrointestinal Stromal Tumor
What this study did
NCT02133196 · National Cancer Institute (NCI)
2014-10-23 – 2027-10-23 · Advanced Non-Small Cell Lung Cancer, Squamous Cell Carcinoma, Advanced NSCLC, Adenosquamous Carcinoma, Adenocarcinoma
What this study did
NCT03449108 · M.D. Anderson Cancer Center
2018-04-27 – 2027-04-30 · Bone Sarcoma, Dedifferentiated Chondrosarcoma, Giant Cell Tumor of Bone, Malignancy in Giant Cell Tumor of Bone, Malignant Solid Neoplasm, Ovarian Carcinosarcoma, Platinum-Resistant Ovarian Carcinoma, Poorly Differentiated Thyroid Gland Carcinoma, Recurrent Osteosarcoma, Recurrent Ovarian Carcinoma, Refractory Osteosarcoma, Soft Tissue Sarcoma, Thyroid Gland Anaplastic Carcinoma, Thyroid Gland Squamous Cell Carcinoma, Undifferentiated High Grade Pleomorphic Sarcoma of Bone, Triple Negative Breast Cancer
What this study did
NCT05686226 · Christian Hinrichs
2023-03-07 – 2027-01-01 · Cervical Cancer, Throat Cancer, Oropharynx Cancer, Anal Cancer, Vulva Cancer, Vaginal Cancer, Penile Cancer, Metastatic Cancer, HPV-Related Malignancy, HPV-Related Carcinoma, HPV-Related Cervical Carcinoma, HPV-Related Squamous Cell Carcinoma, HPV-Related Adenocarcinoma, HPV Positive Oropharyngeal Squamous Cell Carcinoma, HPV-Associated Vaginal Adenocarcinoma, HPV-Related Adenosquamous Carcinoma, HPV-Related Endocervical Adenocarcinoma, HPV-Related Anal Squamous Cell Carcinoma, HPV-Related Penile Squamous Cell Carcinoma, HPV-Related Vulvar Squamous Cell Carcinoma, HPV Positive Rectal Squamous Cell Carcinoma
What this study did
NCT05754684 · Hong Kong Children's Hospital
2022-01-01 – 2025-12-31 · Neuroblastoma Recurrent
What this study did
NCT01857934 · St. Jude Children's Research Hospital
2013-07-05 – 2025-12-31 · Neuroblastoma
What this study did
NCT06690281 · National Cancer Institute (NCI)
2025-09-09 – 2025-09-09 · Gastrointestinal Carcinoma, Pancreatic Cancer, Hepatocellular Cancer, Cholangiocarcinoma, Duodenal Cancer, Colorectal Cancer, Small Bowel Cancer, Metastatic Cancers
What this study did
NCT04893915 · Washington University School of Medicine
2022-06-30 – 2024-12-31 · Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes
What this study did
NCT03610490 · M.D. Anderson Cancer Center
2018-10-16 – 2024-08-21 · Malignant Solid Neoplasm, Metastatic Colorectal Adenocarcinoma, Metastatic Ovarian Carcinoma, Metastatic Pancreatic Ductal Adenocarcinoma, Platinum-Resistant Ovarian Carcinoma, Recurrent High Grade Ovarian Serous Adenocarcinoma, Recurrent Ovarian Carcinosarcoma, Refractory Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v8, Stage IVA Colorectal Cancer AJCC v8, Stage IVB Colorectal Cancer AJCC v8, Stage IVC Colorectal Cancer AJCC v8
What this study did
NCT04102436 · National Cancer Institute (NCI)
2024-03-08 – 2024-03-08 · Endocrine/Neuroendocrine, Non-Small Cell Lung Cancer, Breast Cancer, Gastrointestinal/Genitourinary Cancers, Ovarian Cancer
What this study did
NCT03935347 · Roswell Park Cancer Institute
2019-06-20 – 2023-05-01 · Metastatic Bladder Urothelial Carcinoma, Metastatic Renal Pelvis Urothelial Carcinoma, Metastatic Ureter Urothelial Carcinoma, Metastatic Urethral Urothelial Carcinoma, Unresectable Renal Pelvis Urothelial Carcinoma, Unresectable Ureter Urothelial Carcinoma
What this study did
NCT03412526 · Sheba Medical Center
2018-01-21 – 2022-02-01 · Metastatic Ovarian Cancer
What this study did
Phase 1/2 (39)
Melanoma
NCT06961357 · H. Lee Moffitt Cancer Center and Research Institute
2025-12-03 – 2030-05 · Melanoma
What this study did
NCT02830724 · National Cancer Institute (NCI)
2017-04-06 – 2030-01-01 · Pancreatic Cancer, Renal Cell Cancer, Breast Cancer, Melanoma, Ovarian Cancer
What this study did
NCT05296564 · Hadassah Medical Organization
2022-04-01 – 2027-12-30 · Sarcoma, Synovial, Sarcoma,Soft Tissue, Melanoma Stage IV, Triple Negative Breast Cancer, Metastatic Cancer, Non Small Cell Lung Cancer, Bladder Urothelial Carcinoma, Neuroblastoma, Metastatic, Ovary Cancer
What this study did
NCT01740557 · M.D. Anderson Cancer Center
2015-01-28 – 2023-04-21 · Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7
What this study did
NCT02111850 · National Cancer Institute (NCI)
2014-02-07 – 2021-03-24 · Cervical Cancer, Renal Cancer, Urothelial Cancer, Melanoma, Breast Cancer
What this study did
NCT02354690 · Inge Marie Svane
2014-11 – 2018-12-31 · Metastatic Melanoma
What this study did
NCT02379195 · Inge Marie Svane
2014-11 – 2018-10 · Metastatic Melanoma
What this study did
NCT02153905 · National Cancer Institute (NCI)
2014-07-03 – 2018-09-10 · Breast Cancer, Cervical Cancer, Renal Cancer, Melanoma, Bladder Cancer
What this study did
NCT01218867 · National Cancer Institute (NCI)
2010-11-10 – 2015-12-15 · Metastatic Cancer, Metastatic Melanoma, Renal Cancer
What this study did
NCT00871481 · Fred Hutchinson Cancer Center
2009-02 – 2013-10 · Recurrent Melanoma, Stage IV Melanoma
What this study did
NCT00924001 · National Cancer Institute (NCI)
2007-08 – 2010-10 · Melanoma, Malignant Melanoma, Melanoma, Experimental
What this study did
Other / comorbidity
NCT03190941 · National Cancer Institute (NCI)
2017-09-21 – 2030-06-29 · Pancreatic Cancer, Gastric Cancer, Gastrointestinal Cancer, Colon Cancer, Rectal Cancer
What this study did
NCT05639972 · Christian Hinrichs
2025-08-11 – 2028-10-01 · HPV-Associated Cervical Carcinoma, HPV-Related Carcinoma, HPV-Related Malignancy, HPV Positive Oropharyngeal Squamous Cell Carcinoma, HPV-Related Adenocarcinoma, HPV-Related Adenosquamous Carcinoma, HPV-Related Squamous Cell Carcinoma, HPV-Related Anal Squamous Cell Carcinoma, HPV-Related Penile Squamous Cell Carcinoma, HPV-Related Vulvar Squamous Cell Carcinoma, HPV-Related Endocervical Adenocarcinoma, Cervical Cancer, Oropharynx Cancer, Anal Cancer, Vulvar Cancer, Penile Cancer, Vaginal Cancer
What this study did
NCT05566223 · Intima Bioscience, Inc.
2023-02 – 2027-11 · Carcinoma, Non-Small-Cell Lung, Metastatic Non Small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer, Squamous Cell Lung Cancer, Adenocarcinoma of Lung, Large Cell Lung Cancer
What this study did
NCT04347616 · Radboud University Medical Center
2020-12-03 – 2026-01-30 · Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, Relapsed, Adult
What this study did
NCT04426669 · Intima Bioscience, Inc.
2020-05-15 – 2026-01-22 · Gastrointestinal Epithelial Cancer, Gastrointestinal Neoplasms, Cancer of Gastrointestinal Tract, Cancer, Gastrointestinal, Gastrointestinal Cancer, Colo-rectal Cancer, Pancreatic Cancer, Gall Bladder Cancer, Colon Cancer, Esophageal Cancer, Stomach Cancer
What this study did
NCT03658785 · Tongji Hospital
2020-04-28 – 2025-12-31 · Recurrence Tumor, Metastatic Cancer, Solid Tumor
What this study did
NCT04389229 · Immetacyte Ltd
2020-07-01 – 2025-07-31 · Ovarian Cancer Metastatic
What this study did
NCT03318900 · M.D. Anderson Cancer Center
2018-09-04 – 2023-12-20 · COL6A3 Positive, HLA-A*0201 Positive Cells Present, PRAME Positive, Recurrent Ovarian Carcinoma
What this study did
NCT05194735 · Alaunos Therapeutics
2022-04-04 – 2023-10-11 · Gynecologic Cancer, Colorectal Cancer, Pancreatic Cancer, Non-small Cell Lung Cancer, Cholangiocarcinoma, Ovarian Cancer, Endometrial Cancer, Ovarian Carcinoma, Ovary Neoplasm, Squamous Cell Lung Cancer, Adenocarcinoma of Lung, Adenosquamous Cell Lung Cancer
What this study did
NCT03745326 · National Cancer Institute (NCI)
2019-05-16 – 2022-08-23 · Gastrointestinal Cancer, Pancreatic Cancer, Gastric Cancer, Colon Cancer, Rectal Cancer
What this study did
NCT01823198 · M.D. Anderson Cancer Center
2013-06-11 – 2022-05-10 · Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia in Remission, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blasts Under 20 Percent of Bone Marrow Nucleated Cells, Blasts Under 20 Percent of Peripheral Blood White Cells, Chronic Myelomonocytic Leukemia, High Risk Myelodysplastic Syndrome, Myelodysplastic Syndrome, Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Therapy-Related Acute Myeloid Leukemia, Therapy-Related Myelodysplastic Syndrome
What this study did
NCT01898793 · Washington University School of Medicine
2014-08-11 – 2022-04-04 · Leukemia, Myeloid, Acute
What this study did
NCT00924326 · National Cancer Institute (NCI)
2009-02-17 – 2021-11-17 · Primary Mediastinal B-cell Lymphoma, Diffuse, Large B-cell Lymphoma, Diffuse Large B-Cell Lymphoma Transformed From Follicular Lymphoma, Mantle Cell
What this study did
NCT02620865 · Barbara Ann Karmanos Cancer Institute
2015-12 – 2021-06-21 · Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer
What this study did
NCT03778619 · GC Cell Corporation
2018-11-28 – 2020-10-30 · Relapsed Non Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma
What this study did
NCT02414945 · University Health Network, Toronto
2015-05-15 – 2020-10 · Pleural Mesothelioma
What this study did
NCT03296137 · Inge Marie Svane
2017-10-13 – 2020-07-01 · Cancer
What this study did
NCT02770820 · Fred Hutchinson Cancer Center
2017-11-06 – 2020-06-01 · Acute Myeloid Leukemia, EBV-Positive Neoplastic Cells Present, HLA-A*0201 Positive Cells Present, Blasts Under 5 Percent of Bone Marrow Nucleated Cells, Elevated WT1
What this study did
NCT03287674 · Inge Marie Svane
2017-10-09 – 2020-06-01 · Metastatic Ovarian Cancer
What this study did
NCT01454596 · National Cancer Institute (NCI)
2012-05-16 – 2019-01-17 · Malignant Glioma, Glioblastoma, Brain Cancer, Gliosarcoma
What this study did
NCT01583686 · National Cancer Institute (NCI)
2012-05-04 – 2018-12-17 · Cervical Cancer, Pancreatic Cancer, Ovarian Cancer, Mesothelioma, Lung Cancer
What this study did
NCT02315118 · National University Hospital, Singapore
2014-12 – 2018-12 · B-Cell Chronic Lymphocytic Leukemia, Non-Hodgkin's Lymphoma
What this study did
NCT02390739 · National Cancer Institute (NCI)
2015-03-02 – 2017-03-22 · Metastatic Thyroid Cancer
What this study did
NCT02280811 · National Cancer Institute (NCI)
2014-10-14 – 2016-06-28 · Vaginal Cancer, Cervical Cancer, Anal Cancer, Penile Cancer, Oropharyngeal Cancer
What this study did
NCT01758458 · Fred Hutchinson Cancer Center
2013-02 – 2016-05 · Recurrent Merkel Cell Carcinoma, Stage IV Merkel Cell Carcinoma
What this study did
NCT00303667 · Masonic Cancer Center, University of Minnesota
2005-01 – 2011-03 · Acute Myelogenous Leukemia
What this study did
NCT00924287 · National Cancer Institute (NCI)
2008-11 – 2010-12 · Metastatic Cancer
What this study did
NCT00625729 · Masonic Cancer Center, University of Minnesota
2008-01 – 2010-04 · Leukemia, Lymphoma
What this study did
Phase 1 (65)
Melanoma
NCT07183852 · Vastra Gotaland Region
2027-01 – 2033-03 · Metastatic Uveal Melanoma, Metastatic Cutaneous Melanoma
What this study did
NCT05903937 · Vastra Gotaland Region
2027-01-31 – 2031-12-31 · Uveal Melanoma, Metastatic Cutaneous Melanoma
What this study did
NCT06190249 · James Isaacs, MD
2024-12-02 – 2028-07 · Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IIID Melanoma
What this study did
NCT06204991 · Inge Marie Svane
2025-04-01 – 2028-04-01 · Melanoma Stage III, Melanoma Stage IV, Melanoma
What this study did
NCT01955460 · M.D. Anderson Cancer Center
2014-10-15 – 2027-10-30 · Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7
What this study did
NCT05902520 · AgonOx, Inc.
2023-06-19 – 2026-12-31 · HNSCC, Melanoma, Gynecologic Cancer, Colorectal Cancer, Lung Cancer, Urogenital Cancer
What this study did
NCT01946373 · Karolinska University Hospital
2013-10 – 2025-12 · Melanoma
What this study did
NCT03068624 · M.D. Anderson Cancer Center
2017-09-08 – 2025-07-31 · Metastatic Malignant Neoplasm in the Liver, Metastatic Uveal Melanoma
What this study did
NCT04812470 · Vastra Gotaland Region
2023-02-06 – 2025-05-26 · Metastatic Uveal Melanoma, Metastatic Cutaneous Melanoma
What this study did
NCT05628883 · H. Lee Moffitt Cancer Center and Research Institute
2022-11-22 – 2025-03-06 · Metastatic Melanoma, Unresectable Melanoma, Acral Melanoma, Mucosal Melanoma, Cutaneous Melanoma, Ocular Melanoma, Uveal Melanoma, Iris Melanoma, Conjunctival Melanoma, Non-Cutaneous Melanoma
What this study did
NCT03475134 · Centre Hospitalier Universitaire Vaudois
2018-02-21 – 2024-06-06 · Metastatic Melanoma
What this study did
NCT03991741 · Gregory Daniels
2020-10-07 – 2023-01-26 · Metastatic Melanoma, Locally Advanced Refractory/Recurrent Melanoma, Metastatic Head and Neck Cancer, Locally Advanced Refractory/Recurrent Head and Neck Cancer
What this study did
NCT02652455 · H. Lee Moffitt Cancer Center and Research Institute
2016-03-08 – 2020-08-30 · Melanoma (Skin), Skin Cancer
What this study did
NCT03158935 · University Health Network, Toronto
2017-07-07 – 2020-08-04 · Advanced Ovarian Cancer, Malignant Melanoma
What this study did
NCT01585415 · National Cancer Institute (NCI)
2012-04-09 – 2016-07-21 · Metastatic Cancer, Melanoma
What this study did
NCT02489266 · National Cancer Institute (NCI)
2015-06-24 – 2016-06-29 · Metastatic Melanoma
What this study did
Renal Cell Carcinoma
NCT06626256 · City of Hope Medical Center
2025-12-05 – 2027-10-30 · Locally Advanced Cervical Carcinoma, Locally Advanced Colorectal Carcinoma, Locally Advanced Malignant Solid Neoplasm, Locally Advanced Melanoma, Locally Advanced Pancreatic Ductal Adenocarcinoma, Locally Advanced Renal Cell Carcinoma, Metastatic Cervical Carcinoma, Metastatic Colorectal Carcinoma, Metastatic Malignant Solid Neoplasm, Metastatic Melanoma, Metastatic Pancreatic Ductal Adenocarcinoma, Metastatic Renal Cell Carcinoma, Stage II Pancreatic Cancer AJCC v8, Stage III Cervical Cancer AJCC v8, Stage III Colorectal Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8, Stage III Renal Cell Cancer AJCC v8, Stage IV Cervical Cancer AJCC v8, Stage IV Colorectal Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8, Unresectable Cervical Carcinoma, Unresectable Colorectal Carcinoma, Unresectable Malignant Solid Neoplasm, Unresectable Melanoma, Unresectable Pancreatic Ductal Adenocarcinoma, Unresectable Renal Cell Carcinoma
What this study did
NCT02926053 · Inge Marie Svane
2016-12 – 2021-10-31 · Metastatic Renal Cell Carcinoma
What this study did
Other / comorbidity
NCT07192900 · David Bartlett, MD
2026-06-03 – 2038-04 · Malignant Pleural Effusion, Malignant Mesothelioma, Pleural Effusion, Malignant, Metastasis to Pleura
What this study did
NCT07443020 · Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
2026-05 – 2038-03 · Malignant Pleural Effusion, Malignant Mesothelioma, Pleural Effusion, Malignant, Metastasis to Pleura
What this study did
NCT03017131 · Roswell Park Cancer Institute
2017-12-08 – 2032-03-23 · Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma
What this study did
NCT06321484 · Dana-Farber Cancer Institute
2024-10-09 – 2031-10-31 · Platinum-resistant Ovarian Cancer, Recurrent Ovary Cancer, Ovarian Cancer, Ovarian Carcinoma, Ovarian Carcinoma, Recurrent, Endometroid Ovarian Carcinoma, Clear Cell Ovarian Carcinoma
What this study did
NCT05483491 · Christian Hinrichs
2022-09-26 – 2030-12-31 · Gastric Cancer, Breast Cancer, Cervical Cancer, Lung Cancer
What this study did
NCT06047977 · H. Lee Moffitt Cancer Center and Research Institute
2025-06-02 – 2029-09-01 · Lymphocytes
What this study did
NCT06253520 · National Cancer Institute (NCI)
2024-05-16 – 2029-02-20 · Metastatic Solid Cancers, Colorectal Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Gastrointestinal Cancer, Ovarian Cancer, Genitourinary Cancer
What this study did
NCT05989828 · University of Southern California
2024-12-17 – 2028-12-31 · Triple Negative Breast Cancer
What this study did
NCT06255028 · Century Therapeutics, Inc.
2025-02-06 – 2028-08 · Systemic Lupus Erythematosus, Lupus Nephritis, Idiopathic Inflammatory Myopathies, Diffuse Cutaneous Systemic Sclerosis
What this study did
NCT05681780 · H. Lee Moffitt Cancer Center and Research Institute
2023-03-10 – 2027-12 · Non Small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer, Recurrent Non Small Cell Lung Cancer
What this study did
NCT07225439 · Paolo Caimi, MD
2026-09 – 2027-12 · Non Hodgkin Lymphoma, B-cell Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Primary Mediastinal Large B Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Marginal Zone Lymphoma, Mantle Cell Lymphoma
What this study did
NCT06138587 · Dana-Farber Cancer Institute
2024-01-24 – 2027-11-30 · Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid, Myelodysplastic Syndromes, Myeloproliferative Neoplasm, Myeloproliferative Disorders
What this study did
NCT06152809 · Dana-Farber Cancer Institute
2024-02-20 – 2027-11-30 · Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent, Leukemia, Leukemia, Myeloid
What this study did
NCT05400122 · David Wald
2022-09-09 – 2027-06-01 · Colorectal Cancer, Hematologic Malignancy, Rectum Cancer, Acute Myeloid Leukemia, Myelodysplastic Syndromes, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, Hodgkin Lymphoma, Non Hodgkin Lymphoma, Myeloproliferative Syndrome, Plasma Cell Myeloma, Gastric Cancer, Esophageal Cancer, Esophagus Cancer, Gastric Cancer, Metastatic, Unresectable Esophageal Cancer, Metastatic Esophageal Cancer
What this study did
NCT01883297 · University Health Network, Toronto
2015-01 – 2027-06 · Recurrent, Platinum-resistant, High Grade Serous Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
What this study did
NCT03666000 · Imugene Limited
2019-03-11 – 2027-06 · Non-Hodgkin Lymphoma, B-cell Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
What this study did
NCT05141474 · Vall d'Hebron Institute of Oncology
2021-10-28 – 2027-01-01 · Epithelial Tumors, Malignant, Malignant Solid Tumor
What this study did
NCT06107894 · NeogenTC
2025-02-10 – 2026-02-28 · Advanced Breast Cancer, Advanced Lung Cancer
What this study did
NCT05035407 · National Cancer Institute (NCI)
2022-03-08 – 2025-07-16 · Kita-kyushu Lung Cancer Antigen 1, Human
What this study did
NCT05336409 · Century Therapeutics, Inc.
2023-01-24 – 2025-07-01 · R/R CD19-Positive B-Cell Malignancies, Indolent Non-Hodgkin Lymphoma, Aggressive Non-Hodgkin Lymphoma
What this study did
NCT04634435 · Biohaven Pharmaceuticals, Inc.
2021-10-21 – 2025-01-10 · Multiple Myeloma
What this study did
NCT03691376 · Roswell Park Cancer Institute
2019-03-08 – 2024-06-24 · Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal Carcinoma, Platinum-Sensitive Fallopian Tube Carcinoma, Platinum-Sensitive Ovarian Carcinoma, Platinum-Sensitive Primary Peritoneal Carcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma, Refractory Fallopian Tube Carcinoma, Refractory Ovarian Carcinoma, Refractory Primary Peritoneal Carcinoma
What this study did
NCT03240861 · Jonsson Comprehensive Cancer Center
2017-07-26 – 2023-10-19 · HLA-A*0201 Positive Cells Present, Locally Advanced Malignant Neoplasm, NY-ESO-1 Positive, Unresectable Malignant Neoplasm, Sarcoma
What this study did
NCT04052334 · H. Lee Moffitt Cancer Center and Research Institute
2019-09-27 – 2023-06-16 · Sarcoma
What this study did
NCT03215810 · H. Lee Moffitt Cancer Center and Research Institute
2017-10-11 – 2023-06-09 · Non-Small Cell Lung Cancer, Metastatic Non-small Cell Lung Cancer, Squamous Cell Carcinoma, Advanced NSCLC, Adenosquamous Carcinoma, Adenocarcinomas
What this study did
NCT03450122 · M.D. Anderson Cancer Center
2018-09-13 – 2022-12-06 · HLA-A*0201 Positive Cells Present, NY-ESO-1 Positive Tumor Cells Present, Recurrent Myxoid Liposarcoma, Recurrent Synovial Sarcoma
What this study did
NCT03970382 · PACT Pharma, Inc.
2019-07-03 – 2022-08-12 · Solid Tumor
What this study did
NCT02772679 · Jeffrey Bluestone
2016-08 – 2021-08-27 · Type 1 Diabetes Mellitus
What this study did
NCT03213964 · Masonic Cancer Center, University of Minnesota
2017-10-19 – 2021-03-10 · Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
What this study did
NCT03992326 · Centre Hospitalier Universitaire Vaudois
2019-09-01 – 2021-03-05 · Solid Tumor, Adult
What this study did
NCT03197025 · National Cancer Institute (NCI)
2018-01-09 – 2020-10-16 · Human Papillomavirus, HPV-16, High Grade Squamous Intraepithelial Lesion
What this study did
NCT02757391 · M.D. Anderson Cancer Center
2019-08-09 – 2020-10-02 · Colorectal Adenocarcinoma, Metastatic Cholangiocarcinoma, Metastatic Colorectal Carcinoma, Metastatic Digestive System Carcinoma, Metastatic Esophageal Carcinoma, Metastatic Gastric Carcinoma, Metastatic Pancreatic Adenocarcinoma, Stage IV Colorectal Cancer AJCC v7, Stage IV Esophageal Cancer AJCC v7, Stage IV Gastric Cancer AJCC v7, Stage IV Pancreatic Cancer AJCC v6 and v7, Stage IVA Colorectal Cancer AJCC v7, Stage IVB Colorectal Cancer AJCC v7
What this study did
Early phase / not applicable (3)
Melanoma
NCT01701674 · H. Lee Moffitt Cancer Center and Research Institute
2012-10-09 – 2025-08-21 · Metastatic Melanoma
What this study did
NCT01005745 · H. Lee Moffitt Cancer Center and Research Institute
2009-10-20 – 2025-08-18 · Metastatic Melanoma
What this study did
Other / comorbidity
NCT00187096 · St. Jude Children's Research Hospital
2005-09 – 2013-03 · Acute Myeloid Leukemia
What this study did
Appears in other studies (1)

Studies that reference this drug without giving it an intervention arm of its own: other formulations' programs, background therapy, or registry-search bleed.

Phase 2 (1)
Renal Cell Carcinoma
NCT03501381 · Roberto Pili
2018-05-24 – 2024-04 · Renal Cell Carcinoma
What this study did

Competitive landscape

This drug's own stage for Melanoma: Approved. Competitors below are sorted furthest-along first.

DrugStageModalityMechanismEvidence signalReported efficacygraded featured trials
Aldesleukin (Proleukin): this drugApprovedRecombinant Cytokine (il-2)Interleukin-2 receptor (IL-2R)not yet gradedNo reviewed efficacy summary in this indication
AtezolizumabApprovedMonoclonal antibodyPD-L1not yet gradedNo reviewed efficacy summary in this indication
BinimetinibApprovedSmall moleculeMEK1/2Partial signal
NCT01763164: Progression-Free Survival (PFS) by Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 (From the date of randomization to the date of the first documented PD or death, whichever occurred first (maximum up to 77 weeks for binimetinib arm; maximum up to 61 weeks for dacarbazine arm)): Binimetinib (MEK162) 2.83 Months (95% CI 2.76 to 3.55) | Dacarbazine 1.51 Months (95% CI 1.48 to 1.71)
CobimetinibApprovedSmall moleculeMEK1/2Reliable signalNo reviewed efficacy summary in this indication
DabrafenibApprovedSmall moleculeBRAF V600E/V600K/V600D (also wild-type BRAF/CRAF)Reliable signal
NCT01597908: Overall Survival (OS) (From the date of randomization until date of death due to any cause (up to approximately 6 years)): Dabrafenib Plus Trametinib 26 Months (95% CI 22.1 to 33.8) | Vemurafenib 17.8 Months (95% CI 15.6 to 20.7)
NCT01584648: Progression-Free Survival (PFS) as Assessed by the Investigator (From randomization until the earliest date of disease progression (PD) or death due to any cause (up to approximately 6 years)): Dabrafenib + Trametinib 10.2 Months (95% CI 8.1 to 12.8) | Dabrafenib + Placebo 8.8 Months (95% CI 5.9 to 9.3)
EncorafenibApprovedSmall moleculeBRAF V600EPartial signalNo reviewed efficacy summary in this indication
Interferon Alfa-2b (Intron A)ApprovedBiologic (subtype unspecified)Type I interferon receptorPartial signal
NCT01359956: Overall survival, interferon alfa-2b added vs not added to dacarbazine-based chemotherapy (2x2 factorial): HR 0.92 (95% CI 0.70 to 1.20), p=0.68 (Daponte et al., J Transl Med 2013). missed
IpilimumabApprovedMonoclonal antibodyCTLA-4 antagonistPartial signal
NCT00094653: Overall Survival (OS) (Time-to-Death) Difference Between MDX-010 in Combination With gp 100 Melanoma Peptide Vaccine Versus gp 100 Melanoma Peptide Vaccine Alone (From randomization until the end of the study, which was defined as the time at which 481 deaths were observed (264 weeks)): Ipilimumab Plus gp100 9.95 months (95% CI 8.48 to 11.5) | gp100 6.44 months (95% CI 5.49 to 8.71)
Lifileucel (Amtagvi)ApprovedCell therapyTumor-infiltrating lymphocytes (polyclonal tumor antigens)not yet gradedNo reviewed efficacy summary in this indication
NivolumabApprovedMonoclonal antibodyPD-1Partial signal
NCT02388906: Recurrence-free Survival (RFS) (up to 36 months): Nivolumab 3 mg/kg 52.37 Months | Ipilimumab 10 mg/kg 24.08 Months (95% CI 16.56 to 35.09)
NCT01721746: CheckMate 037 coprimaries: objective response rate 31.7% (95% CI 23.5 to 40.8) in the first 120 nivolumab patients vs 10.6% (3.5 to 23.1) with investigator-choice chemotherapy at the interim analysis, reported without a between-group p-value; overall survival median 16 vs 14 months (HR 0.95, 95.54% CI 0.73 to 1.24), no difference (Weber, Lancet Oncol 2015; Larkin, JCO 2018). missed
Opdivo QvantigApprovedMonoclonal antibodyPD-1not yet gradedNo reviewed efficacy summary in this indication
PembrolizumabApprovedMonoclonal antibodyPD-1Partial signalNo reviewed efficacy summary in this indication
Pembrolizumab Berahyaluronidase Alfa (Keytruda Qlex)ApprovedMonoclonal antibodyPD-1Partial signalNo reviewed efficacy summary in this indication
RelatlimabApprovedMonoclonal antibodyLAG-3Reliable signal
NCT03470922: Progression Free Survival (PFS) (From randomization to date of first documented tumor progression or death (up to approximately 33 months)): Arm A: Relatlimab + Nivolumab 10.12 Months (95% CI 6.37 to 15.74) | Arm B: Nivolumab 4.63 Months (95% CI 3.38 to 5.62)
Tecentriq Hybreza (atezolizumab And Hyaluronidase-Tqjs)ApprovedMonoclonal antibodyPD-L1not yet gradedNo reviewed efficacy summary in this indication
TrametinibApprovedSmall moleculeMEK1/2Weak signalNo reviewed efficacy summary in this indication
VemurafenibApprovedSmall moleculeBRAF (V600 mutant)Partial signalNo reviewed efficacy summary in this indication
Vusolimogene Oderparepvec (Tudriqev)ApprovedOncolytic virusNo discrete molecular targetnot yet gradedNo reviewed efficacy summary in this indication
CemiplimabPhase 3Monoclonal antibodyPD-1not yet gradedNo reviewed efficacy summary in this indication
FianlimabPhase 3Monoclonal antibodyLAG-3not yet gradedNo reviewed efficacy summary in this indication
Intismeran AutogenePhase 3VaccinePatient-specific tumor neoantigens (personalized, up to 34 per patient)not yet gradedNo reviewed efficacy summary in this indication
Tebentafusp-Tebn (KIMMTRAK)Phase 3Protein / enzyme therapeuticgp100-HLA-A*02:01 x CD3Partial signalNo reviewed efficacy summary in this indication
LNS8801Phase 2/3Small moleculeGPER (G protein-coupled estrogen receptor)not yet gradedNo reviewed efficacy summary in this indication
ResiquimodPhase 2/3Small moleculeToll-like receptor 7 and 8 (TLR7/8)not yet gradedNo reviewed efficacy summary in this indication
HS-IT101Phase 2Cell therapyAutologous tumor neoantigens (polyclonal, patient-specific)not yet gradedNo reviewed efficacy summary in this indication
VSV-IFNβ-NISPhase 2Oncolytic virusOncolytic VSV expressing interferon-beta and NISnot yet gradedNo reviewed efficacy summary in this indication
EvalstotugPhase 1/2Biologic (subtype unspecified)CTLA-4not yet gradedNo reviewed efficacy summary in this indication
OBX-115Phase 1/2Cell therapyIL-15 receptor signalingnot yet gradedNo reviewed efficacy summary in this indication
CRX100Phase 1Cell therapyCell-based oncolytic virus immunotherapynot yet gradedNo reviewed efficacy summary in this indication
NaporafenibDiscontinuedSmall moleculePan-RAFnot yet gradedNo reviewed efficacy summary in this indication

Upcoming events

(23 total)

Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.

Follow Proleukin (aldesleukin) to get an email as a readout nears, when a date moves, or when a study changes status. Needs a free account.

Add these readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.

2027 (10)
January 2027 (3)
Phase 1Mesothelioma, Malignant, PD-L1 Negative, Advanced Cancer, Progressive DiseaseActive not recruiting
Est. primary completion 2027-01 · NCT03546426 · CT.gov ↗
What to watch
Phase 1/2MelanomaActive not recruiting
Est. primary completion 2027-01-01 · NCT06237881 · CT.gov ↗
What to watch
Phase 1Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8, Stage IVB Lung Cancer AJCC v8Recruiting
Est. primary completion 2027-01-07 · NCT05493566 · CT.gov ↗
What to watch
February 2027 (1)
Phase 1/2MelanomaRecruiting
Est. primary completion 2027-02-28 · NCT05267626 · CT.gov ↗
What to watch
April 2027 (4)
Phase 1/2Metastatic Colorectal Cancer, Prostate Cancer Metastatic, Prostate Cancer Locally AdvancedRecruiting
Est. primary completion 2027-04 · NCT07255664 · CT.gov ↗
What to watch
Phase 2Head Neck Tumors, Neuroendocrine Tumors, Soft Tissue Sarcoma, Rare Cancer, VaccinationRecruiting
Est. primary completion 2027-04 · NCT04166006 · CT.gov ↗
What to watch
Phase 2Pancreatic Cancer, Surgery, Metastasis, ImmunosuppressionNot yet recruiting
Est. primary completion 2027-04-01 · NCT05810792 · CT.gov ↗
What to watch
Phase 1Clinical Stage IV Gastric Cancer AJCC v8, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Metastatic Gastric Carcinoma …Active not recruiting
Est. primary completion 2027-04-24 · NCT05802056 · CT.gov ↗
What to watch
June 2027 (1)
Phase 1/2Crohn DiseaseRecruiting
Est. primary completion 2027-06-30 · NCT04263831 · CT.gov ↗
What to watch
September 2027 (1)
Phase 1/2MelanomaRecruiting
Est. primary completion 2027-09-01 · NCT07063875 · CT.gov ↗
What to watch
2028 (5)
April 2028 (1)
Phase 1/2Triple Negative Breast CancerNot yet recruiting
Est. primary completion 2028-04 · NCT05821686 · CT.gov ↗
What to watch
June 2028 (1)
Phase 2Alzheimer DiseaseActive not recruiting
Est. primary completion 2028-06-08 · NCT05468073 · CT.gov ↗
What to watch
September 2028 (1)
Phase 1/2AML, Childhood, Aml, Acute Myeloid Leukemia, Pediatric, Acute Myeloid LeukemiaRecruiting
Est. primary completion 2028-09-15 · NCT06158828 · CT.gov ↗
What to watch
October 2028 (1)
Phase 1MelanomaNot yet recruiting
Est. primary completion 2028-10-01 · NCT07700121 · CT.gov ↗
What to watch
November 2028 (1)
Early phase / not applicableCoronary Artery Disease, Myocardial Infarction (MI), CABGRecruiting
Est. primary completion 2028-11-01 · NCT07610538 · CT.gov ↗
What to watch
2029 (3)
April 2029 (2)
Phase 1Malignancy, Hematologic, Neoplasms, Hematologic, Neoplasms, Hematopoietic, Blood Cancer, Hematological Neoplasms …Recruiting
Est. primary completion 2029-04-30 · NCT06904066 · CT.gov ↗
What to watch
Phase 1/2MelanomaActive not recruiting
Est. primary completion 2029-04-30 · NCT01590069 · CT.gov ↗
What to watch
June 2029 (1)
Phase 1/2Alzheimer Dementia (AD)Recruiting
Est. primary completion 2029-06 · NCT07651319 · CT.gov ↗
What to watch
2030 (1)
March 2030 (1)
Phase 1/2Relapsed Adult AML, Refractory AML, Acute Myelogenous LeukemiaRecruiting
Est. primary completion 2030-03-01 · NCT07591649 · CT.gov ↗
What to watch
2031 (3)
March 2031 (1)
Phase 1/2Relapsed or Refractory Multiple MyelomaRecruiting
Est. primary completion 2031-03-06 · NCT07681596 · CT.gov ↗
What to watch
September 2031 (1)
Phase 2Renal Cell CarcinomaRecruiting
Est. primary completion 2031-09-01 · NCT05155033 · CT.gov ↗
What to watch
December 2031 (1)
Phase 1/2Ovarian Cancer, Advanced Malignant Solid TumorRecruiting
Est. primary completion 2031-12-10 · NCT07389239 · CT.gov ↗
What to watch
2039 (1)
August 2039 (1)
Phase 1/2Select Advanced Solid TumorsRecruiting
Est. primary completion 2039-08-01 · NCT06598371 · CT.gov ↗
What to watch

See the full readout calendar ↗